Human vaginal histology in long-term users of the injectable contraceptive depot-medroxyprogesterone acetate

Contraception

Volumn 90, Issue 2, 2014, Pages 117-122

  Bahamondes, M Valeria ^a   Castro, Sara ^a   Marchi, Nadia M ^a   Marcovici, Michele ^a   Andrade, Liliana A L A ^a   Fernandes, Arlete ^a   Bahamondes, Luis ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Injectable contraceptive; Long term users; Reproductive age; Vaginal histology

Indexed keywords

ESTRADIOL; INJECTABLE CONTRACEPTIVE AGENT; MEDROXYPROGESTERONE ACETATE; CONTRACEPTIVE AGENT; DELAYED RELEASE FORMULATION;

ARTICLE; CELL COUNT; EPITHELIUM CELL; ESTRADIOL BLOOD LEVEL; HISTOLOGY; INTRAUTERINE CONTRACEPTIVE DEVICE; LANGERHANS CELL; VAGINA; VAGINA EPITHELIUM; VAGINA MUCOSA; ADULT; BLOOD; BRAZIL; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; CYTOLOGY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; FEMALE; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; MIDDLE AGED; MUCOSA; ORGAN SIZE; OUTPATIENT DEPARTMENT; REPRODUCIBILITY; TIME; UNIVERSITY HOSPITAL;

ADULT; BRAZIL; CELL COUNT; CONTRACEPTIVE AGENTS, FEMALE; CROSS-SECTIONAL STUDIES; DELAYED-ACTION PREPARATIONS; ESTRADIOL; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INTRAUTERINE DEVICES; LANGERHANS CELLS; MEDROXYPROGESTERONE ACETATE; MIDDLE AGED; MUCOUS MEMBRANE; ORGAN SIZE; OUTPATIENT CLINICS, HOSPITAL; REPRODUCIBILITY OF RESULTS; TIME FACTORS; VAGINA;

EID: 84904264032     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2014.01.024     Document Type: Article

References (34)

1. C. Westhoff Depot-medroxyprogesterone acetate injection (Depo-Provera): a highly effective contraceptive option with proven long-term safety Contraception 68 2003 75 87
2. I.S. Fraser, and E. Weisberg A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate Med J Aust 1 Suppl. 1 1981 3 19
3. A.M. Kaunitz Current concepts regarding use of DMPA J Reprod Med 47 9 suppl 2002 785 789
4. B. Winner, J.F. Peipert, and Q. Zhao et al. Effectiveness of long-acting reversible contraception N Engl J Med 366 2012 1998 2007
5. L. Bahamondes, M. Trevisan, and L. Andrade et al. The effect upon the human vaginal histology of the long-term use of the injectable contraceptive Depo-Provera Contraception 62 2000 23 27
6. C.A. Blish, and J.M. Baeten Hormonal contraception and HIV-1 transmission Am J Reprod Immunol 65 2011 302 307
7. K. Ungchusak, T. Rehle, P. Thammapornpilap, D. Spiegelman, U. Brinkman, and T. Siraprapasiri Determinants of HIV infection among female commercial sex workers in Northeastern Thailand results from a longitudinal study J Acquir Immun Defic Syndr 12 1996 500 507
8. T. Rehle, U.K. Brinkmann, and T. Siraprapasiri et al. Risk factors of HIV-1 infection among female prostitutes in Khon Kaen, Northeast Thailand Infection 20 1992 328 331
9. T. Nagachinta, A. Duerr, and V. Suriyanon et al. Risk factors for HIV-1 transmission from HIV-seropositive male blood donors to their regular female partners in Northern Thailand AIDS 11 1997 1765 1772
10. M. Bulterys, A. Chão, P. Habimana, A. Dushimimana, P. Nawrocki, and A. Saah Incident HIV-1 infection in a cohort of young women in Butare, Rwanda AIDS 8 1994 1585 1591
11. C.K. Mauck, M.M. Callahan, and J. Baker et al. The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy Contraception 60 1999 15 24
12. L. Miller, D.L. Patton, A. Meier, S.S. Thwin, T.M. Hooton, and D.A. Eschenbach Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium Obstet Gynecol 96 2000 431 439
13. A.K. Ildgruben, I.M. Sjöberg, and M.L. Hammarström Influence of hormonal contraceptives on the immune cells and thickness of human vaginal epithelium Obstet Gynecol 102 2003 571 582
14. R. Heffron, D. Donnell, and H. Rees et al. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study Lancet Infect Dis 12 2012 19 26
15. A.K. Jain Hormonal contraception and HIV acquisition risk: implications for individual users and public policies Contraception 86 2012 645 652
16. J.P. Connor, K. Ferrer, J.P. Kane, and J.M. Goldberg Evaluation of Langerhan's cells in cervical epithelium of women with cervical intraepithelial neoplasia Gynecol Oncol 75 1999 130 135
17. F. Wieser, J. Hosmann, W. Tschugguel, K. Czerwenka, R. Sedivy, and J.C. Huber Progesterone increases the number of Langerhans cells in human vaginal epithelium Fertil Steril 75 2001 1234 1235
18. J. Hu, M. Pope, C. Brown, U. O'Doherty, and C.J. Miller Immunophenotypic characterization of simian immunodeficiency virus-infected dendritic cells in cervix, vagina, and draining lymph nodes of rhesus monkeys Lab Invest 78 1998 435 451
19. P.A. Marx, A.I. Spira, and A. Gettie et al. Progesterone implants enhance SIV vaginal transmission and early virus load Nat Med 102 1996 1083 1089
20. S. Hild-Petito, R.S. Veazey, J.M. Larner, J.R. Reel, and R.P. Blye Effects of two progestin-only contraceptives, Depo-provera and Norplant II, on the vaginal epithelium of rhesus monkeys AIDS Res Human Retroviruses 14 Suppl. 1 1998 S125 S130
21. C. Costello Daly, G.E. Helling-Giese, J.K. Mati, and D.J. Hunter Contraceptive methods and the transmission of HIV implications for family planning Genitour Med 70 1994 110 117
22. P.H. Kilmarx, K. Limpakarnjanarat, and T.D. Mastro et al. HIV-1 seroconversion in a prospective study of female sex workers in northern Thailand: continued high incidence among brothel-based women AIDS 12 1998 1889 1898
23. S.H. Kapiga, E.F. Lyamuya, G.K. Lwihula, and D.J. Hunter The incidence of HIV infection among women using family planning methods in Dar es Salaam, Tanzania AIDS 12 1998 75 84
24. H.L. Martin Jr., P.M. Nyange, and B.A. Richardson et al. Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1 J Infect Dis 178 1998 1053 1059
25. M. Kiddugavu, F. Makumbi, and M.J. Wawer et al. Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda AIDS 17 2003 233 240
26. L. Lavreys, J.M. Baeten, and H.L. Martin Jr. et al. Hormonal contraception and risk of HIV-1 acquisition: results of a 10-year prospective study AIDS 18 2004 695 697
27. J.M. Baeten, S. Benki, and V. Chohan et al. Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women AIDS 21 2007 1771 1777
28. H. Wand, and G. Ramjee The effects of injectable hormonal contraceptives on HIV seroconversion and on sexually transmitted infections AIDS 26 2012 375 380
29. C.S. Morrison, B.A. Richardson, and F. Mmiro et al. Hormonal contraception and the risk of HIV acquisition AIDS 21 2007 85 95
30. C.S. Morrison, S. Skoler-Karpoff, and C. Kwok et al. Hormonal contraception and the risk of HIV acquisition among women in South Africa AIDS 26 2012 497 504
31. L. Myer, L. Denny, T.C. Wright, and L. Kuhn Prospective study of hormonal contraception and women's risk of HIV infection in South Africa Int J Epidemiol 36 2007 166 174
32. R. Heffron, E. Were, and C. Celum et al. A prospective study of contraceptive use among African women in HIV-1 serodiscordant partnerships Sex Transm Dis 37 2010 621 628
33. R. Heffron, N. Mugo, and K. Ngure et al. Hormonal contraceptive use and risk of HIV-1 disease progression AIDS 27 2013 261 267
34. R. Wilcher, T. Petruney, and W. Cates The role of family planning in elimination of new pediatric HIV infection Curr Opin HIV AIDS 8 2013 490 497